DOTA-NOC acetate is a somatostatin-analog peptide with a chelating domain used to study receptor binding and metal coordination. Its structure supports mapping of somatostatin receptor interactions. Researchers evaluate its folding to characterize motif accessibility. The DOTA group adds versatility for analytical applications.
CAT No: M34140626H
CAS No:619300-53-7
Synonyms/Alias:Dotanoc;DOTA-NOC;DOTA-nal3-octreotide;1IIY9GZY9U;UNII-1IIY9GZY9U;619300-53-7;L-Cysteinamide, N-(2-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl)acetyl)-D-phenylalanyl-L-cysteinyl-3-(1-naphthalenyl)-L-alanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2->7)-disulfide;CHEMBL4297373;HY-P2112;CS-0108508;
3. Implications of ligand-receptor binding kinetics on GLP-1R signalling
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More